• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇激酶1通过AKT信号通路增强非小细胞肺癌细胞的侵袭和迁移能力。

Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway.

作者信息

Zhu Liangming, Wang Zhou, Lin Yuxia, Chen Zhitao, Liu Haibo, Chen Ying, Wang Ningning, Song Xiue

机构信息

Department of Thoracic Surgery, Jinan Central Hospital, Shandong University, Jinan, Shandong 250013, P.R. China.

Department of Thoracic Surgery, Shandong Province Hospital, Shandong University, Jinan, Shandong 250013, P.R. China.

出版信息

Oncol Rep. 2015 Mar;33(3):1257-63. doi: 10.3892/or.2014.3683. Epub 2014 Dec 19.

DOI:10.3892/or.2014.3683
PMID:25529771
Abstract

Sphingosine kinase 1 (SphK1) has been shown to play an important role in the progression of a number of human cancers. It has been reported that the expression of SphK1 is greatly elevated in non-small cell lung cancer (NSCLC) tissues. However, its role and underlying mechanisms in NSCLC have not been fully elucidated. In the present study, we found that SphK1 was highly expressed in NSCLC cells. Overexpression of SphK1 promoted the invasion and migration of NSCLC cells, while knockdown of SphK1 suppressed the invasion and migration. Furthermore, we demonstrated that SphK1 decreased the protein level of E-cadherin, yet increased the protein level of Snail. In addition, SphK1 was able to stimulate the activation of AKT. Inhibition of the AKT pathway attenuated the biological functions of NSCLC cells induced by overexpression of SphK1. Taken together, our findings suggest that SphK1 can enhance the invasion and migration of NSCLC cells via activation of the AKT pathway and regulation of E-cadherin and Snail expression. Thus, SphK1 could be a potential target for the detection and treatment of NSCLC.

摘要

鞘氨醇激酶1(SphK1)已被证明在多种人类癌症的进展中起重要作用。据报道,SphK1在非小细胞肺癌(NSCLC)组织中的表达显著升高。然而,其在NSCLC中的作用及潜在机制尚未完全阐明。在本研究中,我们发现SphK1在NSCLC细胞中高表达。SphK1的过表达促进了NSCLC细胞的侵袭和迁移,而敲低SphK1则抑制了侵袭和迁移。此外,我们证明SphK1降低了E-钙黏蛋白的蛋白水平,但增加了Snail的蛋白水平。另外,SphK1能够刺激AKT的激活。抑制AKT途径减弱了SphK1过表达诱导的NSCLC细胞的生物学功能。综上所述,我们的研究结果表明,SphK1可通过激活AKT途径以及调节E-钙黏蛋白和Snail的表达来增强NSCLC细胞的侵袭和迁移。因此,SphK1可能是NSCLC检测和治疗的潜在靶点。

相似文献

1
Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway.鞘氨醇激酶1通过AKT信号通路增强非小细胞肺癌细胞的侵袭和迁移能力。
Oncol Rep. 2015 Mar;33(3):1257-63. doi: 10.3892/or.2014.3683. Epub 2014 Dec 19.
2
LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.长链非编码 RNA HULC 通过上调鞘氨醇激酶 1(SPHK1)及其下游的 PI3K/Akt 通路促进非小细胞肺癌细胞增殖并抑制细胞凋亡。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8722-8730. doi: 10.26355/eurrev_201812_16637.
3
Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer.敲低 CPEB4 表达通过 Akt 通路抑制非小细胞肺癌细胞迁移和侵袭。
Cell Biol Int. 2018 Nov;42(11):1484-1491. doi: 10.1002/cbin.10930. Epub 2018 Feb 1.
4
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3β pathway in non-small cell lung cancer.CNPY2 通过激活 AKT/GSK3β 通路促进非小细胞肺癌上皮间质转化。
Cell Biol Int. 2018 Aug;42(8):959-964. doi: 10.1002/cbin.10961. Epub 2018 Apr 17.
5
Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.CASS4的过表达通过激活AKT信号通路和抑制E-钙黏蛋白的表达促进非小细胞肺癌的侵袭。
Tumour Biol. 2016 Nov;37(11):15157-15164. doi: 10.1007/s13277-016-5411-5. Epub 2016 Sep 27.
6
Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.鞘氨醇激酶 1 通过激活人非小细胞肺癌中的 PI3K/Akt/NF-κB 通路增强细胞凋亡抵抗。
Clin Cancer Res. 2011 Apr 1;17(7):1839-49. doi: 10.1158/1078-0432.CCR-10-0720. Epub 2011 Feb 15.
7
The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.音猬因子信号通路通过激活Akt和c-Met刺激间变性甲状腺癌细胞的运动性和侵袭性。
Oncotarget. 2016 Mar 1;7(9):10472-85. doi: 10.18632/oncotarget.7228.
8
Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.细胞黏附分子 4 通过抑制非小细胞肺癌中的 Akt 信号通路抑制细胞生长和转移。
Int J Biochem Cell Biol. 2020 Jun;123:105750. doi: 10.1016/j.biocel.2020.105750. Epub 2020 Apr 20.
9
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).M2型乙酰胆碱受体/核因子κB信号轴失活可逆转非小细胞肺癌(NSCLC)中的上皮-间质转化(EMT),并抑制其迁移和侵袭。
Oncotarget. 2015 Oct 6;6(30):29335-46. doi: 10.18632/oncotarget.5004.
10
BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.BMP2 通过激活磷脂酰肌醇 3-激酶(PI3K)/Akt 通路加速胃癌细胞的迁移和侵袭。
Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14.

引用本文的文献

1
Is Sphingosine Kinase 1 Associated with Hematological Malignancy? A Systematic Review and Meta-Analysis.丝氨酸棕榈酰转移酶 1 与血液系统恶性肿瘤有关吗?系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2605-2613. doi: 10.31557/APJCP.2024.25.8.2605.
2
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer.癌症中通过碳水化合物和脂质代谢对自噬的调控
Cancers (Basel). 2023 Apr 7;15(8):2195. doi: 10.3390/cancers15082195.
3
Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail.
阿霉素诱导的鞘氨醇激酶 1 上调通过稳定 Snail 产生血管生成反应。
FASEB J. 2023 Mar;37(3):e22787. doi: 10.1096/fj.202201066R.
4
Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis.整合荟萃分析中的代谢物与转录组学揭示了胰腺炎背景下 PDAC 中 SPHK1 的增强。
BMC Cancer. 2022 Jul 19;22(1):792. doi: 10.1186/s12885-022-09816-6.
5
Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.新型双重抑制剂 SKI-349 通过靶向鞘氨醇激酶 1/2 抑制非小细胞肺癌细胞生长。
Cell Death Dis. 2022 Jul 12;13(7):602. doi: 10.1038/s41419-022-05049-4.
6
Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target.肺癌中的鞘脂代谢与信号传导:一个潜在的治疗靶点
J Oncol. 2022 Jun 28;2022:9099612. doi: 10.1155/2022/9099612. eCollection 2022.
7
Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells.鞘氨醇激酶1信号通路在乳腺癌中的作用:一种靶向乳腺癌干细胞的潜在靶点
Front Mol Biosci. 2021 Nov 8;8:748470. doi: 10.3389/fmolb.2021.748470. eCollection 2021.
8
The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620.mTOR激酶抑制剂PQR620对非小细胞肺癌细胞的活性作用
Front Oncol. 2021 Jun 10;11:669518. doi: 10.3389/fonc.2021.669518. eCollection 2021.
9
The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.鞘氨醇激酶 1 的致瘤作用及其潜在的治疗靶点。
Cancer Control. 2020 Jan-Dec;27(1):1073274820976664. doi: 10.1177/1073274820976664.
10
GDC-0349 inhibits non-small cell lung cancer cell growth.GDC-0349 抑制非小细胞肺癌细胞生长。
Cell Death Dis. 2020 Nov 5;11(11):951. doi: 10.1038/s41419-020-03146-w.